With Jim Pickard, Miranda Green, Robert Shrimsley and Henry Mance. Presented by Sebastian Payne.
© The Financial Times Ltd 2016 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
High hopes that new immunotherapy drugs would prove to have benefits over toxic chemotherapy were dashed by large-scale trials, says David Crow. Pharmaceutical groups are now working on combinations of the immunotherapies and using them with chemo, but some pharma groups have suffered big losses and Wall Street has become sceptical